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Abstract
It is not known whether there are mechanisms linking adipose tissue mass and increased oxidative
stress in obesity. This study investigated associations between decreasing general and abdominal fat
depots and oxidative stress during weight loss. Subjects were severely obese women who were
measured serially at baseline and at 1, 6 (n = 30), and 24 months (n = 18) after bariatric surgery.
Total fat mass (FAT) and volumes of visceral (VAT) and subcutaneous abdominal adipose tissue
(SAT) were related to plasma concentrations of derivatives of reactive oxidative metabolites
(dROMS), a measure of lipid peroxides and oxidative stress. After intervention, BMI significantly
decreased, from 47.7 ± 0.8 kg/m2 to 43.3 ± 0.8 kg/m2 (1 month), 35.2 ± 0.8 kg/m2 (6 months), and
30.2 ± 1.2 kg/m2 (24 months). Plasma dROMS also significantly deceased over time. At baseline,
VAT (r = 0.46), FAT (r = 0.42), and BMI (r = 0.37) correlated with 6-month decreases in dROMS.
Similarly, at 1 month, VAT (r = 0.43) and FAT (r = 0.41) correlated with 6-month decreases in
dROMS. Multiple regression analysis showed that relationships between VAT and dROMS were
significant after adjusting for FAT mass. Increased plasma dROMS at baseline were correlated with
decreased concentrations of high-density lipoprotein (HDL) at 1 and 6 months after surgery (r =
−0.38 and −0.42). This study found longitudinal associations between general, and more specifically
intra-abdominal adiposity, and systemic lipid peroxides, suggesting that adipose tissue mass
contributes to oxidative stress.
INTRODUCTION
The world is experiencing an epidemic of obesity that affects (in 2005) >500 million adults,
with the highest rates in the United States (30%), Europe (20%), and the Middle East (20–
25%) (1). As obesity increases the risk of developing metabolic diseases, including diabetes,
cardiovascular disease, hypertension, cancer, dyspnea, and osteoarthritis (2), the prevalence of
these diseases is expected to rise, and this is expected to overburden public health systems.
Given the size of the problem, it will be important to identify pathophysiological factors
potentially related to obesity to define effective prevention and treatment strategies.
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Oxidative stress is commonly identified in many obesity-related diseases and may be the
mechanism underlying the progression/initiation of these diseases. Oxidative stress can be
assessed in vivo by measurement of the products of free radical damage to lipids, proteins, and
DNA in biological fluids (3). Multiple studies have shown the relationship between biomarkers
of oxidative stress and obesity. Obese individuals show higher concentrations of plasma
isoprostanes (4), plasma malondialdehyde (5), skeletal muscle 4-hydroxynonenal (6), and
plasma protein carbonyls (7,8). Severity of obesity is also inversely correlated with specific
antioxidant enzyme activities, including that of CuZn superoxide dismutase and glutathione
peroxidase (9).
Limited data suggest that regimens promoting weight loss result in decreased indices of
oxidative stress in obese individuals. Individuals maintained on a weight-loss diet for 4 weeks
showed a decrease in weight correlated with a decrease in thiobarbituric reactive acid
substances, protein carbonyls, and oxidation of linoleic acids (13-HODE and 9-HODE) in
blood (7). Although these results suggest a relationship between body fat and oxidative stress,
changes may also be due, in part, to the low-fat/carbohydrate and low-calorie diet itself, as diet
has been shown to modulate systemic oxidative stress (10,11). These variables make the
evaluation of the contribution of body fat to systemic oxidative stress difficult.
In this study, systemic oxidative stress was determined in severely obese individuals after
bariatric surgery–induced weight loss. Patients were measured at baseline (before weight loss)
and serially for up to 24 months after surgery. During the study, we determined markers of
oxidative stress, using the derivatives of reactive oxidative metabolites (dROMS) test, which
measures plasma peroxides, and plasma nitrotyrosine, which measures oxidized amino acids.
Data show decreases in systemic oxidative stress with weight loss and a longitudinal
relationship between adiposity and oxidative stress.
METHODS AND PROCEDURES
Patients
The study subjects were 30 severely obese female patients who had weight-loss treatment at
the Emory Bariatrics Center either via laparoscopic roux-en-y gastric bypass surgery (n = 28),
or via adjustable banding (n = 2) (12). This was a longitudinal study in which each patient
served as her own control. Subjects were evaluated at baseline (before surgery) and at 1, 6, and
24 months after surgery. Subjects were eligible for surgery after evaluation (clinical,
psychological, and nutritional) when they were recruited for the study. Exclusion criteria were
(i) male gender, (ii) age <18 years or >65 years, (iii) BMI <35 kg/m2, and (iv) current smoking
history. All medication, including that used to treat metabolic syndrome, was monitored
throughout the study. For a subset of consecutively enrolled subjects, diet history, using 3-day
food records, was collected at each study visit and analyzed using Food Processor SQL (ESHA
Research, Salem, OR).
Measurements of glucose tolerance, anthropometry, adipose tissue distribution, oxidative
stress, and plasma inflammatory biomarkers were obtained at baseline (before treatment) and
at 1, 6, and 24 months after surgery. During the week before the baseline, 6-month, and 24-
month postsurgery time points, subjects were weight stable (±1 kg) (13). These steady-state
conditions not were feasible at the time of the 1-month weight-loss studies, when patients were
showing ~3 kg/week weight loss, but measures were obtained at this time to capture potentially
informative variables. Medications were withheld from patients on the morning of glucose
tolerance testing.
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Insulin action was assessed using the frequently sampled intravenous glucose tolerance test.
Patients were admitted into the Emory General Clinical Research Center on the night before
testing and fasted over-night (12 h). An intravenous catheter was inserted into an antecubital
vein for blood sampling. Baseline samples were obtained at −15 and −5 min. Glucose (0.3 g/
kg body weight, as dextrose 50 g/dl) was then administered within 2 min, and subsequent
samples were obtained at 2, 4, 6, 8, 10, 14, 19, 22, 24, 27, 30, 40, 50, 70, 90, 120, 150, 180,
210, and 240 min relative to the start of glucose infusion. At 20 min, subjects received an
intravenous bolus of human insulin (0.02 U/kg body weight). Minimal modeling analysis of
glucose and insulin levels (14) was used to quantify insulin sensitivity, insulin secretion, and
the disposition index (MinMod Millennium, Los Angeles, CA). Fasting concentrations of
glucose and insulin were used to calculate the homeostatic model assessment measure of insulin
resistance, HOMA-IR = insulin (μU/ml) × glucose (mmol/l)/22.5 (15).
Anthropometry, body composition, and fat distribution
Body fat composition was measured by air plethysmography (BOD-POD; Life Measurement
Instruments, Concord, CA). Abdominal fat distribution was measured by computed
tomography, using a GE High Speed Advantage scanner (General Electric Medical Systems,
Milwaukee, WI) as described elsewhere (16). Volumes of visceral adipose tissue (VAT) and
subcutaneous adipose tissue (SAT) were determined from scans taken in the L1–L5 vertebral
region (140 kV, 240–340 mA·s, 10 mm slice thickness). Adipose tissue within an attenuation
range of −190 to −30 Hounsfield units was highlighted and computed using software (General
Electric Medical Systems). In our scanner we are able to analyze patients with body weight up
to 182 kg (400 lb). Sagittal abdominal diameter was obtained at the L4–L5 intervertebral space
using an abdominal caliper (17). Body height was measured without shoes. Body weight was
measured with subjects in light clothing, in the fasting state, and immediately after voiding in
the morning. Waist circumference was taken using a tape measure at 2.54 cm above the iliac
crest, and hip circumference was determined as the maximum value over the buttocks.
Metabolic measures
Serum insulin and glucose concentrations were quantified at the Emory University Hospital
Laboratory using the Beckman Coulter DX1 and Beckman Coulter Alex 20 automated systems,
respectively (Beckman Coulter, Brea, CA). The limit of the assay for insulin was 1 μU/ml and
that for glucose was 0.17 mmol/l. Plasma leptin was measured using a commercial human
enzyme-linked immunosorbent assay kit (Diagnostic Systems Laboratory, Webster, TX). The
inter-and intraassay variability were 4.4 and 4.0%, respectively. Plasma resistin, adiponectin,
IL-6 (high sensitivity), and TNF-α (high sensitivity) were measured using commercial human
enzyme-linked immunosorbent assay kits (R&D Systems, Minneapolis, MN). Serum high-
sensitivity C-reactive protein was measured using the SYNCHRON LX20 high-sensitivity
immunoassay (Beckman Coulter, Fullerton, CA). The sensitivity of the assay is 0.07 mg/dl.
Free fatty acids were measured by ARUP Laboratories (Salt Lake City, UT). Oxidative stress
was measured in plasma using the dROMS assay, which measures serum hydroperoxide levels
(dROMS Test; Diacron, Grosseto, Italy). This parameter has been used to measure oxidants in
blood, and its usefulness as a biomarker has been demonstrated in several studies (18–21).
Plasma concentrations of nitrotyrosine and tyrosine were measured by mass spectrometry
following procedures reported previously (22). In brief, each sample was delipidated, desalted,
and hydrolyzed for 24 h under an argon atmosphere. Amino-acid hydrolysates were
resuspended and washed using mini solid-phase C18 extraction columns and then analyzed
using liquid chromatography with tandem mass spectrometry (SCIEX API 3000; Applied
Biosystems, Foster City, CA). Nitrotyrosine and tyrosine levels were determined by stable
isotope-labeled standards, 3-nitro(13C9 15N1)tyrosine and tyrosine (13C9 15N1), respectively.
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The statistical software STATISTICA (StatSoft, Tulsa, OK) was used for analysis. The
differences between baseline and 1-, 6-, and 24-month postsurgery measures were analyzed
using paired Student’s t-tests. The relationships between changes in various metabolic and
anthropometrical parameters were examined as linear correlations using Pearson’s correlation
coefficient. Data that were not normally distributed were analyzed using Spearman’s rank order
correlations. For most relationships, significant correlations were observed whether or not
subjects who underwent adjustable banding were excluded. The significance level was set at
P < 0.05. Results are expressed as mean ± s.e.m.
The Emory University Institutional Review Board approved the study, and all patients gave
informed consent before they were enrolled.
RESULTS
Baseline patient characteristics
Thirty subjects completed the full longitudinal analysis up to 6 months after surgery, and 18
of these were evaluated again at 24 months. At baseline, their average age was 36.1 ± 1.6 years
(range 24–55 years), and 20% of the women were postmenopausal. Nine women were self-
described as non-Hispanic blacks, 17 were non-Hispanic whites, one was Native American,
and three were Hispanic. The mean BMI was 47.7 ± 0.8 kg/m2 (range 39.4–55.3 kg/m2). All
women had abdominal obesity (waist circumference >88 cm), and 22 subjects (73% of patients)
had two other criteria of Adult Treatment Panel III–defined metabolic syndrome (low high-
density lipoprotein (HDL), high triglycerides, hypertension, and/or glucose intolerance) (23).
Six patients (20% of the population), had type 2 diabetes as defined elsewhere (24) and were
taking medication to improve insulin action.
Changes in adiposity and anthropometry after weight-loss surgery
After bariatric surgery, patients experienced weight loss as a result of reduction in energy intake
from 1,695 ± 99 to 821 ± 172 kcal/day at 1 month and 1,128 ± 105 kcal/day at 6 months (both
P < 0.05, obtained from 3-day food records; n = 8–13). At 24 months after surgery, caloric
intake was 1,433 kcal/day. No significant changes were observed in dietary macronutrient
content (carbohydrate, fat, and protein) as a percentage of energy intake during the 24-month
period after surgery (data not shown). Changes in anthropometry during the 24-month period
are reported in Table 1. The two surgical interventions achieved similar weight loss; therefore
the data were pooled for analysis. Compared with baseline, significant decreases were observed
in both fat mass (FAT) and lean body mass at 1, 6, and 24 months after surgery, but more fat
than lean mass was lost at all time points (P < 0.000). In the acute 1-month period after surgery,
subjects lost VAT but not SAT in the abdominal area; they experienced decreases in both depots
at 6 and 24 months. Subjects lost a higher percentage of VAT than of SAT at 1, 6, and 24
months after surgery (P < 0.000 for 1 and 6 months; P < 0.05 at 24 months). Also, sagittal
abdominal diameter was significantly decreased from baseline as early as 1 month after surgery,
and waist circumference was not significantly decreased until 6 months after surgery.
Changes in cardiometabolic risk factors after weight-loss surgery
The number of subjects with Adult Treatment Panel III–defined metabolic syndrome decreased
from 76% at baseline to 41%, 21%, and 24% at 1, 6, and 24 months, respectively (P < 0.05,
compared with baseline; Table 2). Compared with baseline, HDL concentrations worsened at
1 month and increased by 24 months after surgery, but they remained abnormally low in 53%
of subjects. In this series of subjects, we reported earlier that glucose tolerance improved at 6
months after surgery as a result of selective changes in hepatic insulin resistance (homeostatic
Gletsu-Miller et al. Page 4













model assessment measure of insulin resistance), β-cell function (acute insulin response to
glucose and disposition index), and peripheral insulin sensitivity, and diabetes was resolved
in all but one patient by 6 months after surgery (25). In this article we report similar changes
in these parameters in these patients during the 24-month period after surgery and relationships
to changes in oxidative stress.
Changes in oxidative stress after weight-loss surgery
Oxidative stress, measured by the dROMS lipid peroxides assay, progressively decreased
during weight loss, from 0.047 ± 0.003 absorbance units at baseline to 0.039 ± 0.003 at 1 month,
0.027 ± 0.002 at 6 months, and 0.020 ± 0.002 at 24 months (P < 0.05; Figure 1). As a measure
of oxidatively damaged proteins, plasma concentrations of nitrotyrosine (N-Tyr) were
measured and normalized to plasma tyrosine (Tyr) levels. N-Tyr measured in a subset of four
individuals was increased from baseline (1.5 ± 0.4 nmol N-Tyr/mol Tyr) at 1 month after
surgery (2.8 ± 0.6 nmol N-Tyr/mol Tyr) and then decreased compared with baseline at 6 months
(1.0 ± 0.3 nmol N-Tyr/mol Tyr) and 24 months (0.7 ± 0.3 nmol N-Tyr/mol Tyr) (P < 0.05 in
all cases).
Relationships between oxidative stress and anthropometry
The time since surgery had a significant effect on systemic dROMS concentrations over the
24-month period (P < 0.05) (Figure 1). To determine whether decreased measures of oxidative
stress were associated with decreasing adiposity, linear cross-sectional and longitudinal
correlation analyses were performed between plasma dROMS and various measures of
adiposity. Larger preoperative measures of VAT, waist circumference, FAT, BMI, and body
weight predicted larger decreases in dROMS during the initial 6-month period of postsurgical
weight loss (Figure 2). In contrast, no significant relationship was observed between
preoperative SAT and dROMS over time (data not shown). In addition, 1-month-postsurgery
measures of VAT, FAT, BMI, and body weight predicted 6-month reduction in dROMS (Figure
3). The correlations between change in dROMS and VAT volumes were stronger than the
correlations with FAT mass. Also, multiple regression analysis (Table 3) showed that the
relationship between the change in dROMS levels and preoperative or 1-month measures of
VAT mass remained significant when adjusting for FAT mass. In contrast, the relationships
between FAT and dROMS were no longer significant after adjusting for VAT. This suggests
that visceral adiposity makes a more specific contribution to systemic dROMS concentrations
than general adiposity. In addition, a correlation approaching significance was observed
between baseline VAT volumes and the change in dROMS over 24 months (r = 0.41, P = 0.09,
n = 18). No relationship was found between FAT mass and changes in dROMS over the same
period (r = 0.13, P = 0.6). These results, taken together, strongly suggest that changes in plasma
dROMS concentrations, which represent systemic lipid peroxides, may be regulated by
adiposity, with visceral adiposity playing the largest role. No cross-sectional relationships were
observed between adiposity variables and dROMS at any specific time point. In addition, no
cross-sectional or longitudinal relationships were observed between lean mass, dietary
carbohydrate, fat, or protein intake and plasma dROMS concentration during any of the
measurement periods.
Relationships between oxidative stress and cardiometabolic risk
We examined relationships between oxidative stress and measures of cardiometabolic risk and
glucose metabolism at baseline and during weight loss. Plasma HDL concentrations at 1 and
6 months were negatively predicted by the baseline plasma dROMS concentrations (r = −0.38
and −0.42, P = 0.05 and 0.02, respectively) (Figure 4). HDL concentrations were not associated
with any measures of adiposity, and FAT as a covariate in multivariate analysis did not
confound the relationship between dROMS and HDL (data not shown). Although dROMS was
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found to be associated with measures of adiposity shown to be risk factors for glucose
intolerance, no correlations were found between plasma dROMS and insulin resistance or β-
cell function.
DISCUSSION
The major findings of this study are that markers of oxidative stress indicative of damaged
lipids (dROMS) and proteins (nitrotyrosine) are decreased in severely obese women followed
during weight loss for 24 months. Increased baseline measures of adiposity, including total fat
mass and VAT volume, predicted larger postoperative falls in lipid peroxides, suggesting that
adipose tissue contributes to systemic oxidative stress. Furthermore, plasma lipid peroxide
concentrations negatively predicted HDL levels. These data point to a close relationship
between central adiposity, oxidative stress, and cardiometabolic risk.
Insulin resistance and other features of metabolic syndrome are commonly found in obesity,
but the mechanisms linking these phenomena are not fully understood. To explore causal
mechanisms, we tested longitudinal relationships between general and central adiposity,
diabetogenic adipokines, and metabolic syndrome in studies of severely obese women
undergoing weight loss via bariatric surgery. We previously demonstrated in this series of
subjects that changes in systemic inflammation owing to decreased C-reactive protein and
increased adiponectin predicted improved peripheral and hepatic insulin resistance measured
in vivo using the frequently sampled intravenous glucose tolerance test (25,26). As oxidative
stress has been shown to be increased in obesity and inflammatory states (27), we determined
whether decrease in fat mass over a period of 24 months after bariatric surgery would affect
measures of oxidative stress and whether decreases in oxidative stress would correlate to
improvements in cardiometabolic risk.
Data from this study suggest that adipose tissue contributes to systemic concentrations of
oxidatively modified lipids. Plasma lipid peroxides measured by dROMS specifically and
persistently decreased with decreasing adiposity over the period of weight loss of 24 months.
The decrease in lipid peroxides over 6 months of weight loss was predicted by baseline as well
as 1-month postoperative measures of adiposity. More specifically, visceral adiposity appeared
to contribute independently to changes in dROMS when compared to general adiposity.
Changes in dROMS over 6 months of weight loss were more predictable by adiposity measures
than those changes measured over 1 and 24 months of weight loss. Also interesting is that no
cross-sectional relationships were observed between adiposity variables and dROMS at any
time point. Taken together, these data suggest that the effects of adipose tissue on dROMS are
more apparent during dynamic states of weight loss, such as from baseline to 6 months, than
during states of minimal weight loss or during weight stability. Future studies should determine
the kinetics and regulation of the formation of lipid peroxides from adipose tissue.
An increase in markers of oxidative damage in obesity (5,28–30) and reduction after weight
loss intervention such as bariatric surgery (8,31), caloric restriction for 4 weeks (7) and 12
months (32), exercise for 6 months (33,34), and orlistat pharmacotherapy for 6 months (35)
has been shown. Consistent with our study findings, some of these intervention studies (33,
35) demonstrated longitudinal relationships between BMI and lipid peroxides. As we obtained
more precise measures of fat and lean mass, as well as dietary analysis, our study demonstrates,
for the first time, specific associations between adiposity and lipid peroxides—a measure of
oxidative damage. Plasma nitrotyrosine, another measure of oxidative stress, also decreased
in a small subset of study subjects over the 24-month weight-loss period. The findings in our
study demonstrate that associations between obesity and oxidative stress are also found in states
of extreme obesity and during weight loss.
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In support of the observational data in this and the aforementioned human studies, accumulating
evidence supports the concept that adipose tissue contributes to systemic lipid peroxides and
that this contribution is exaggerated with increasing adiposity. Recent studies have
demonstrated that reactive oxygen species production increased (29), and an oxidized redox
state (36) was found in adipose tissue of obese compared with lean rodents. Also, in obese
states, increasing amounts of macrophages and lymphocytes reside in adipose tissue and, in
combination with adipocytes, may release free radicals (37–40). Macrophage concentrations
decrease in adipose tissue in patients undergoing weight loss (41,42). Taken together, this
evidence suggests that factors associated with adipose tissue may generate oxidized lipid by-
products and that the quantity and/or activity of these factors diminishes during weight loss.
In terms of adipose tissue distribution, this study’s findings and those of recent cross-sectional
studies propose that visceral fat is more strongly associated with oxidative stress than
abdominal subcutaneous fat or general adiposity (43,44). The approach used in this study was
more informative than that of other studies, as we took direct measures of abdominal VAT and
SAT volumes and of total fat mass during weight loss. We report that relative to total fat mass,
intra-abdominal adiposity as determined by VAT volumes appears to be a stronger determinant
of oxidative stress. Whether visceral and subcutaneous adipose depots vary in oxidation status
has not been determined in humans. However, limited evidence suggests that antioxidant
defenses, including catalase and glutathione peroxidase, were reduced in epidydimal (intra-
abdominal) fat pads in obese Zucker rats compared with those in inguinal (subcutaneous) fat
pads (36).
Diabetes (45) and cardiovascular disease (46), as well as cardiometabolic risk factors,
dyslipidemia (47), insulin resistance (48), and hypertension (49), have been characterized by
increased oxidative stress. In this study, we found that preoperative plasma dROMS negatively
predicted postoperative systemic HDL concentrations. HDL is known to have antioxidant
properties owing to associated paraoxonase enzyme activity (50). This enzyme inactivates lipid
peroxides and reduces the accumulation of oxidized lipids in LDL, and its activity is inversely
correlated with severity of cardiovascular disease (51). Our observations suggest that high
systemic peroxides at baseline may have adverse and long-term effects on concentrations of
HDL. This finding may explain why HDL concentrations were low preoperatively and did not
normalize for many subjects until after 6 months postsurgery. Potential mechanisms mediating
the effects of lipid peroxides on concentrations and antioxidant capacity of HDL remain to be
explored.
Although longitudinal correlations were found in this study linking fat mass and central
adiposity to oxidative stress, and oxidative stress to HDL, which are established biomarkers
of cardiometabolic risk, these findings are observational. The heterogeneity of study subjects
with respect to race and glucose tolerance can be regarded as both a strength and weakness of
the study. The relationships reported appeared to be uniform, as findings were similar whether
or not subjects with diabetes were included. Although diet composition was not found to predict
changes in dROMS, we acknowledge that these measures were obtained from self-reported
measures of food take, which are known to be less precise. Further studies with larger sample
sizes, including men and also subjects undergoing lifestyle (diet and exercise) and
pharmacological interventions, may reveal whether longitudinal associations between
oxidative stress and obesity are to be found in other populations of patients during weight loss.
Also, it is important to note that although various assays are used to measure oxidative damage,
this study measured primarily lipid peroxides. Thus, the effects of fat mass on other oxidatively
damaged molecules remain to be determined.
In summary, we here demonstrate, for the first time in a longitudinal clinical study, that VAT
volume and, to a lesser extent, total adipose tissue mass are specific determinants of plasma
Gletsu-Miller et al. Page 7













concentrations of lipid peroxides—an indicator of systemic oxidative stress. Thus, oxidative
stress decreased as adipose tissue decreased during weight loss in the acute and long-term
periods. We showed that baseline concentrations of plasma lipid peroxides were related to
decreases during weight loss in concentrations of HDL, which functions as an antioxidant.
Taken together, our data suggest that adipose tissue volumes determine indices of systemic
oxidative stress, which, in turn, may be involved in the etiology linking obesity to
cardiometabolic disease.
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Changes in systemic concentrations of lipid peroxides in severely obese subjects during 24
months after bariatric surgery. Plasma was collected and stored at baseline and 1, 6, and 24
months (n = 30, 28, 30, and 18, respectively) and assessed for lipid peroxides using the
derivatives of reactive oxidative metabolites (dROMS) assay. *P < 0.05, ‡P < 0.0001 compared
to baseline using paired Student’s t-tests.
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Correlations between baseline measures of adiposity and changes in dROMS over 6 months
after surgery. Pearson’s correlation coefficients (r) between percentage changes in plasma
derivatives of reactive oxidative metabolites (dROMS) over 6 months and (a) preoperative
body fat mass (FAT), (b) BMI, (c) body weight (WT), and (d) abdominal visceral adipose
tissue volumes (VAT) were determined (n = 30). As indicated in the figure, all correlation
coefficients were significant.
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Pearson’s correlation coefficients (r) between percentage changes over 6 months in systemic
dROMS and (a) body fat mass (FAT), (b) BMI, (c) body weight (WT), and (d) abdominal
visceral adipose tissue volumes (VAT) at 1 month after surgery were determined (n = 29). As
indicated in the figure, correlation coefficients between dROMS and VAT, FAT, and WT were
significant.
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Correlations between systemic concentrations of lipid peroxides and high-density lipoproteins
(HDLs). Spearman’s correlation coefficients (r) were determined for preoperative plasma
dROMS vs. plasma HDL concentrations at baseline and 1 and 6 months after surgery (n = 29,
27, and 29, respectively). As indicated in figure, correlations between baseline dROMS and
HDL concentrations at 1 and 6 months after surgery were significant (P < 0.05).
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Table 3





VAT baseline 0.46 0.38
VAT 1 month 0.43 0.36
FAT baseline 0.42 n.s
FAT 1 month 0.41 n.s
Relationships, reported as Pearson’s correlation coefficients, between changes in derivatives of reactive oxidative metabolites (dROMS) over 6 months
of weight loss and visceral adipose tissue volumes (VAT) or fat mass (FAT) at baseline and 1 month after surgery were determined using linear regression
followed by multiple regression analysis by adjusting for FAT or VAT, respectively. Only significant relationships are shown.
P < 0.05, n.s. = not significant; n = 30 at baseline and n = 29 at 1 month.
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